Johnson & Johnson News Pharma

Johnson & Johnson’s Multiple Sclerosis Drug Ponesimod Hits Sanofi Drug Aubagio in Phase 3 Trial

Biotech News | 27.07.2019

Johnson & Johnson announced that it has successfully completed its Phase 3 study program with...